[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100660141":3},{"organization":4,"outcomesModule":7,"designInfo":17,"detailedDescription":11,"studyPopulation":11,"armGroups":24,"interventions":30,"overallOfficials":11,"centralContacts":35,"locations":11,"responsibleParty":41,"collaborators":11,"id":45,"slug":46,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":49,"acronym":11,"eligibilityCriteria":50,"healthyVolunteers":47,"sex":51,"minAge":52,"maxAge":11,"enrollmentInfo":53,"targetDuration":11,"studyType":56,"phases":57,"briefSummary":58,"conditions":59,"keywords":11,"overallStatus":62,"whyStopped":11,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":11},{"fullName":5,"class":6},"Massachusetts General Hospital","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":11},[9],{"measure":10,"description":11,"timeFrame":12},"Feasibility of Non-Contrast-Enhanced MRI Acquisition",null,"12 months",[14],{"measure":15,"description":11,"timeFrame":16},"Agreement Between NC-MRI and CE-MRI","12 Months",{"allocation":18,"interventionModel":19,"interventionModelDescription":20,"primaryPurpose":21,"observationalModel":11,"timePerspective":11,"maskingInfo":22},"NA","SINGLE_GROUP","Single-arm, prospective, within-subject pilot study:","DIAGNOSTIC",{"masking":23,"maskingDescription":11,"whoMasked":11},"NONE",[25],{"label":26,"type":27,"description":11,"interventionNames":28},"Non-Contrast-Enhanced Breast MRI","EXPERIMENTAL",[29],"Device: Non-Contrast-Enhanced Breast MRI",[31],{"type":32,"name":26,"description":33,"armGroupLabels":34,"otherNames":11},"DEVICE","A 5-minute NC-MRI sequence is the research intervention being evaluated",[26],[36],{"name":37,"role":38,"phone":39,"phoneExt":11,"email":40},"HAJER JARRAYA, MD","CONTACT","617-724-9729","hjarraya@mgh.harvard.edu",{"type":42,"investigatorFullName":43,"investigatorTitle":44,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Hajer Jarraya","Principal Investigator","100660141","non-contrast-enhanced-breast-mri-in-the-evaluation-of-newly-diagnosed-breast-cancer-a-pilot-study-100660141",false,"NCT07874256","Non-Contrast-Enhanced Breast MRI in the Evaluation of Newly Diagnosed Breast Cancer: A Pilot Study","Inclusion Criteria:\n\n* Women aged 18 years or older.\n* Pathologically confirmed, newly diagnosed breast cancer.\n* Scheduled to undergo a clinically indicated contrast-enhanced breast MRI (CE-MRI) at Massachusetts General Hospital.\n* Able to provide verbal informed consent as approved by the IRB.\n\nExclusion Criteria:\n\n* Pregnancy.\n* Any contraindication to MRI, including unsafe or non-MRI-compatible implanted medical devices or metallic foreign bodies.\n* Inability to safely undergo breast MRI or remain still for the duration of the examination.\n* Inability to complete the additional approximately 5-minute NC-MRI sequence.","FEMALE","18 Years",{"count":54,"type":55},20,"ESTIMATED","INTERVENTIONAL",[18],"This pilot study is evaluating whether breast MRI without contrast dye can provide useful information in patients who have recently been diagnosed with breast cancer. The study uses MRI techniques to look at breast tissue and the extent of cancer without an intravenous gadolinium injection and compare it to contrast enhanced MRI.",[60,61],"Breast Cancer","Breast Cancer Detection","NOT_YET_RECRUITING","2026-10-09",{"date":65,"type":66},"2026-10-14","ACTUAL",{"date":68,"type":55},"2026-11",{"date":70,"type":55},"2027-11",{"name":5,"class":6}]